Neurological complications following liver transplantation are more common than after other organ transplants. These complications include seizure in about 8% of cases, which is associated with morbidity and mortality. Seizure should be treated immediately, and the process of differential diagnosis has to be performed appropriately in order to avoid permanent neurologic deficit. We herein report a case of status epilepticus after liver transplantation. The status epilepticus was treated promptly and the cause of seizure was assessed. The patient was discharged without any complication.
On ICU 6th day, the extubation was done, she was tolerable with 40% oxygen supply of facial mask. Her mental state was alert and oriented. On ICU 7th day, the patient was transferred to general ward. In the general ward, she spoke nonsense intermittently. After 11 days (postoperative day She was readmitted to the ICU and intubation was done.
Video-EEG was monitored continuously. The antiepileptic drugs were also administered continuously ( (Fig. 3) , so neurologists suspected posterior reversible encephalopathy syndrome (PRES). They recommended the dose reduction or substitution of cytotoxic agents. The surgical team reduced the dose of tacrolimus to half dose for 2 days (2 mg per day). They reduced to the quarter dose following 2 days. After symptoms relieved, dose was increased to 1 mg twice a day (Fig. 2) .
On POD #19, midazolam infusion was stopped, and her mental status resolved to be alert. So, the extubation was done in the next day. One day later, she was transferred to the general ward.
On POD #27, brain MRI showed the improvement of T2 hyperintensity and swelling of the cortex, subcortex of the bilateral temporo-parieto-occipital lobes than before (Fig. 4) . 
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She continued to take anti-epileptic drugs at a reduced dose (Fig. 2) . On POD #32, EEG revealed the successful treatment of epilepticus. On POD #36, she was discharged without complications.
Discussion
The neurological complications after LT are more common than other solid organ transplantation, and include seizures, delirium, impaired consciousness, or focal neurological signs about 13-47%. [5] We should be alert on these symptoms, because they are associated with the prolonged hospital stay and decreased post-LT survival. [4, 6] The status epilepticus is widely defined as a prolonged seizure or multiple seizures with incomplete return to baseline.
[7] It is a neurological emergency. Her laboratory test showed leukocytosis, but she has no source of infection.
The Third, cerebrovascular diseases should be ruled out;
cerebral hemorrhage, ischemic stroke, and subdural hema- After seizure events, the antiepileptic drugs were given promptly, and the process of diagnosis was performed appropriately, so neurologic state was able to be reversible.
To terminate status epilepticus, lorazepam (0.1 mg/kg) is the first-line anti-status agent (typically 1-2 mg in adults, with an additional 2 mg/min, maximum of 8 mg). [9, 16] Levetiracetam is the drug of choice for primary generalized seizure in post-transplant patients because it has no hepatic metabolism or drug-drug interactions. [9] The status epilepticus following LT is not common neurological complications. It is very difficult to discover the primary cause, because the transplant patients have many risk factors and abnormal laboratory findings. However, seizure must be treated promptly to prevent recurrence and further neurological deficits. The medical team has to know the previously mentioned etiology, [9] and be more cautious to manage the seizure after LT.
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